WO2008116852A1 - New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design. - Google Patents
New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design. Download PDFInfo
- Publication number
- WO2008116852A1 WO2008116852A1 PCT/EP2008/053445 EP2008053445W WO2008116852A1 WO 2008116852 A1 WO2008116852 A1 WO 2008116852A1 EP 2008053445 W EP2008053445 W EP 2008053445W WO 2008116852 A1 WO2008116852 A1 WO 2008116852A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- strain
- gene
- propanediol
- evolved
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B10/00—Directed molecular evolution of macromolecules, e.g. RNA, DNA or proteins
Definitions
- the present invention concerns a new method combining evolution and rational design for the preparation of a micro-organism to produce 1 ,2-propanediol, the micro-organism thereby obtained and its use for the preparation of 1 ,2-propanediol.
- propylene glycol a C3 dialcohol
- It is a component of unsaturated polyester resins, liquid detergents, coolants, anti-freeze and de-icing fluids for aircraft.
- Propylene glycol has been increasingly used since 1993-1994 as a replacement for ethylene derivatives, which are recognised as being more toxic than propylene derivatives.
- 1 ,2-propanediol is currently produced by chemical means using a propylene oxide hydration process that consumes large amounts of water.
- Propylene oxide can be produced by either of two processes, one using epichlorhydrin, and the other hydroperoxide. Both routes use highly toxic substances.
- the hydroperoxide route generates by-products such as tert- butanol and 1 -phenyl ethanol. For the production of propylene to be profitable, a use must be found for these by-products.
- the chemical route generally produces racemic 1 ,2-propanediol, whereas each of the two stereoisomers (R)l,2-propanediol and (5)l,2-propanediol are of interest for certain applications (e.g. chiral starting materials for specialty chemicals and pharmaceutical products).
- 6-deoxy sugars e.g. L-rhamnose or L-fucose
- S dihydroxyacetone phosphate
- S-lactaldehyde which can be further reduced to (S)- 1,2- propanediol
- This route is functional in E. coli, but can not yield an economically feasible process due to the elevated cost of the deoxyhexoses.
- the second route is the metabolism of common sugars (e.g. glucose or xylose) through the glycolysis pathway followed by the methylglyoxal pathway.
- Dihydroxyacetone phosphate is converted to methylglyoxal that can be reduced either to lactaldehyde or to acetol.
- These two compounds can then undergo a second reduction reaction yielding 1 ,2-propanediol.
- This route is used by natural producers of (R)-l,2-propanediol, such as Clostridium sphenoides and Thermoanaerobacter thermosaccharolyticum.
- Clostridium sphenoides has been used to produce 1 ,2-propanediol at a titer of 1,58 g/1 under phosphate limited conditions (Tran Din and Gottschalk, 1985). Thermoanaerobacter thermosaccharolyticum has also been investigated for the production of 1 ,2-propanediol (Cameron and Cooney, 1986, Sanchez-Rivera et al, 1987). The best performances obtained were a titer of 9 g/1 and a yield from glucose of 0,2 g/g. However, the improvement of the performances obtained with these organisms is likely to be limited due to the shortage of available genetic tools. PRIOR ART
- the group of Bennett also used an E. coli host strain lacking IdhA for the overexpression of the mgs gene from Clostridium acetobutylicum and the gldA gene firomis. coli. Flask cultures under anaerobic conditions gave a titer of 1.3 g/1 and a yield of 0.12 g/g whereas microaerobic cultures gave a titer of 1.4 g/1 with a yield of 0.13 g/g.
- An alternative method to obtain a strain producing 1 ,2-propanediol is to direct the evolution of an "initial strain" towards a state where the "evolved strain" produces the desired compound with better characteristics.
- This method is based on the natural evolution of a microorganism which is first modified by attenuation of two genes, tpiA and one gene involved in the conversion of methylglyoxal into lactate.
- the purpose for attenuating the tpiA gene coding for triose phosphate isomerase is to separate the two metabolic branches starting at glyceraldehyde-3- phosphate (GA3P) and dihydroxyacetone phosphate (DHAP) that are normally interconverted by this enzyme.
- the pathway from DHPA to 1 ,2-propanediol will be the "reducing branch” consuming reduced co-factors (NADH), whereas the metabolism from GA3P to acetate will be the "oxidative branch” producing NADH and energy for the growth of the cell.
- NADH reduced co-factors
- GA3P reduced co-factors
- oxidative branch producing NADH and energy for the growth of the cell.
- the metabolism of the cell is "locked” and the growth of the strain, the production of 1,2- propanediol and the production of acetate are tightly coupled. Under selection pressure in an appropriate growth medium, this initial strain will evolve to a state where the production of 1,2- propanediol by said strain is improved.
- the present invention concerns a new method combining evolution and rational design for the preparation of a strain of micro-organism for the production of 1 ,2-propanediol from a carbon source.
- the said method comprises: growing an initial strain under selection pressure in an appropriate growth medium, said initial bacterial strain comprising an attenuation of the expression of the tpiA gene and an attenuation the expression of at least one gene involved in the conversion of methylglyoxal to lactate (such as gloA, aldA, aldB), in order to promote evolution in said initial strain, then selecting and isolating the evolved strain having an increased 1,2 propanediol production rate (increased by at least 20%), - then reconstructing a functional tpiA gene in the evolved strain;
- the synthesis of unwanted by-products is attenuated by deleting the genes coding for enzymes involved in synthesis of lactate from pyruvate (idhA), formate (pfl)
- the Entner-Doudoroff pathway is eliminated by deleting either the edd or eda gene or both.
- at least one gene selected among arcA and ndh is attenuated.
- the microorganism used for the preparation of 1 ,2-propanediol is selected among bacteria, yeasts and fungi, but is preferentially from the species Escherichia coli or Clostridium acetobutylicum.
- the present invention also concerns the evolved strain such as obtained, that may be furthermore genetically modified in order to optimize the conversion of a carbon source into 1 ,2- propanediol without by-products and with the best possible yield.
- the glyceraldehyde 3 phosphate dehydrogenase activity is reduced in order to redirect a part of the available glyceraldehyde 3 phosphate toward the synthesis of 1 ,2-propanediol.
- the efficiency of the sugar import is increased, either by using a sugar import independent of phosphoenolpyruvate (PEP) like the one encoded by galP, or by providing more PEP to the sugar-phosphotransferase system.
- PEP phosphoenolpyruvate
- This is obtained by eliminating the pathways consuming PEP like pyruvates kinases (encoded by thepykA andpykF genes) and/or by promoting the synthesis of PEP e. g. by overexpressing the ppsA gene coding for PEP synthase.
- it is valuable for the enzyme converting pyruvate into acetyl-coA to be resistant to high concentrations of NADH found under anaerobic conditions. This can be obtained by a specific mutation in the lpd gene.
- the synthesis of the by-product acetate is prevented by attenuating one or several of the genes ⁇ ckA,pt ⁇ ,poxB.
- This invention is also related to a method for the production of 1 ,2-propanediol at an optimal yield, under aerobic, microaerobic or anaerobic conditions, using said evolved and optionally genetically modified strain of E. coli grown in an appropriate growth medium containing a simple carbon source. Additionally, the invention is related to a method for the production of 1 ,2- propanediol at an optimal yield, under anaerobic conditions, using said evolved and optionally genetically modified strain of C. acetobutylicum grown in an appropriate growth medium containing a simple or a complex carbon source. The produced 1,2 propanediol according to this method is subsequently recovered and optionally purified.
- Figure 1 depicts the genetic engineering of central metabolism in the development of a 1 ,2-propanediol production system from carbohydrates.
- strain' denotes a genetic variant of a species.
- 'strain of microorganism' denotes a genetic variant of a species of a specific microorganism.
- the characteritics given for any strain apply also for the corresponding microorganism or vice versa.
- the terms 'culture', 'growth' and 'fermentation' are used interchangeably to denote the growth of bacteria in an appropriate growth medium containing a simple carbon source.
- the term 'carbon source' according to the present invention denotes any source of carbon that can be used by those skilled in the art to support the normal growth of a micro-organism, and which can be hexoses, pentoses, monosaccharides, disaccharaides, oligosaccharides, starch or its derivatives, hemicelluloses, glycerol and combinations thereof.
- 'appropriate growth medium' denotes a medium of known molecular composition adapted to the growth of the micro-organism and designed in such a way that it promotes the wanted evolution.
- the evolution process according to the invention is a process for the preparation of evolved micro-organisms presenting improved production characteristics, and comprises the following steps: a) Modification of a micro-organism to obtain an initial strain with a "locked" metabolism where the evolution can only take the desired direction when the cells of the initial strain are grown on an appropriate medium, b) Growth of the initial strain obtained above on said appropriate medium in order to cause it to evolve, wherein the initial strain is grown under aerobic, micro-aerobic or anaerobic conditions, c) Selection of the "evolved strains" able to grow under these specific conditions, presenting improved production characteristics for the desired compound.
- the term 'selection' denotes a process wherein the only strains of microorganisms that are retained in the culture medium are those presenting a better fitness under the selection pressure conditions. Typically, the fittest strains are outgrowing their competitors and are then selected.
- a simple way to select a specific evolved strain of microorganism in a population consists in growing the population in continuous culture in which slow-growing strains are eventually eluted from the culture. This is not an exclusive example for selection, and other methods of selection known by the expert in the field may be applied.
- the term 'isolation' denotes a process where an individual strain presenting specific genetic modifications is separated from a population of strains presenting different genetic characteristics. This is done by sampling the biomass after the period of evolution and spreading it on Petri dishes to isolate single colonies.
- 1,2-propanediol production rate means a production rate expressed in g/l/h, that is calculated as follows:
- a specific production rate expressed in g/g/h taking into account the quantity of biomass can be calculated as follows:
- the concentration of biomass is determined either by measuring the absorbance of the fermentation broth with a spectrophotometer reading for example at 600 nm or by determining the dry weight of cells after drying a defined volume of fermentation broth.
- the quantity of 1,2-propanediol produced is measured by high performance liquid chromatography (HPLC) with an adapted column according to a state of the art protocol.
- evolved strains are selected for the following characteristics : an increased glucose uptake rate and an improved 1,2 propanediol production rate.
- the strains showing these characteristics are then isolated, and advantageously compared to each other, in the way to identify the best producer.
- the glucose uptake rate expressed in g/l/h is calculated as follow : Concentration of glucose consumed by the culture (g/1) / time necessary for this consumption (h)
- a specific glucose uptake rate can be calculated by taking into account the concentration of biomass in the medium, as previously described.
- Glucose uptake rate and 1,2 propanediol production rate are intimately linked. If the consumption of glucose is increased, the production of the products from the glucose metabolism is increased in the same proportion.
- the best evolved strains present a glucose uptake that is about 20% higher than the uptake of the initial strain, preferentially about 30% higher or more, more preferentially 50% higher.
- the increased 1,2 propanediol production rate is of about 20% higher than the production rate of the initial strain, preferentially about 30% higher or more, more preferentially about 50% higher.
- the tpih gene encodes the enzyme 'triose phosphate isomerase', which catalyses the interconversion of DHAP and GA3P (see figure 1). The purpose of the attenuation of this gene is to engineer the metabolism of the cell in such a way that the evolution toward the most efficient 1 ,2- propanediol production becomes possible.
- 'attenuation of the expression of a gene' denotes the partial or complete suppression of the expression of a gene, which is then said to be 'attenuated'.
- This suppression of expression can be either an inhibition of the expression of the gene, the suppression of an activating mechanism of the gene, a deletion of all or part of the promoter region necessary for the gene expression, or a deletion in the coding region of the gene.
- the attenuation of a gene is essentially the complete deletion of that gene, which gene can be replaced by a selection marker gene that facilitates the identification, isolation and purification of the strains according to the invention.
- a gene is preferentially inactivated by the technique of homologous recombination as described in Datsenko, K. A. & Wanner, B. L. (2000) "One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products". Proc. Natl. Acad. Sci. USA 97: 6640-6645. Other methods are described below.
- expression refers to the transcription and translation of a gene sequence leading to the generation of the corresponding protein, product of the gene.
- reconstructing a functional tpiA gene in the evolved strain means that the selected evolved strain is modified after the process of evolution by introducing a functional tpiA gene; this can be accomplished by replacing via homologous recombination the attenuated copy of the gene by a wild-type functional copy, thus restoring a triose phosphate isomerase activity similar to the activity measured in the initial strain, or by the introduction of a functional tpiA gene on a different chromosomal locus or by introducing a functional tpiA gene on a plasmid.
- This restoration can allow a yield of 1 ,2-propanediol production from glucose greater than 1 mole/mole by partly recycling GA3P into DHAP for the production of 1 ,2-propanediol through the action of triose phosphate isomerase.
- the purpose of the attenuation of the expression of at least one gene involved in the conversion of methylglyoxal (2-oxo propanal) into lactate is to inhibit the conversion of methylglyoxal into lactate, so that the methylglyoxal present is used by the cell machinery essentially for the synthesis of 1 ,2-propanediol.
- Genes involved in the conversion of methylglyoxal into lactate are in particular: - a gene coding for a glyoxalase, for example the gloA gene coding for glyoxalase I, catalysing the synthesis of lactoyl glutathione from methylglyoxal; the aldA and aldB genes coding for a lactaldehyde dehydrogenase (catalysing the synthesis of (S) lactate from (S) lactaldehyde).
- the expression of one or more of these genes is advantageously attenuated (or the gene is completely deleted) in the initial strain.
- the gloA gene is deleted.
- An additional modification is advantageously made to the initial strain consisting in suppressing the natural glucose fermentation routes, which consume reducing equivalents as NADH and therefore compete with 1 ,2-propanediol biosynthesis pathway.
- Attenuation of at least one of the genes edd and eda coding for the enzymes involved in the Entner-Doudoroff pathway is also useful to prevent the direct metabolism of glucose into glyceraldehyde-3 -phosphate and pyruvate that can bypass the 1 ,2-propanediol synthesis pathway.
- NADH concentration in the cell can also be increased by inactivating the NADH dehydrogenase II encoded by the gene ndh. Therefore, preferably, at least one gene selected among arcA and ndh has its expression attenuated.
- the initial strain is selected from the group consisting of bacteria, yeasts and fungi.
- the initial strain is selected from the group consisting of Enterobacteriaceae, Bacillaceae, Clostridiaceae, Streptomycetaceae and Corynebacteriaceae.
- the initial strain is either Escherichia coli or Clostridium acetobutylicum.
- the evolved strain susceptible to be obtained, and the evolved strain such as obtained by the process previously described, is also an object of the invention.
- the evolved strain is modified by an attenuation of the glyceraldehyde 3 phosphate dehydrogenase (GAPDH) activity, in order to reduce the flux in the lower part of glycolysis and to redirect it toward the synthesis of DHAP and finally 1,2- propanediol (see figure 1).
- GPDH glyceraldehyde 3 phosphate dehydrogenase
- This decreased activity may in particular be obtained by an attenuation of the expression of the gap A gene.
- the efficiency of sugar import is increased.
- PPS sugar-phosphotransferase system
- the sugar-phosphotransferase system (PTS) usually assuring the import of simple sugars into the cell is coupled to a phosphorylation reaction giving glucose-6-phosphate.
- the phosphate needed for this reaction is provided by the conversion of PEP into pyruvate.
- deacreasing the amount of PEP produced by reducing the flux through glyceraldehyde-3 -phosphate reduces sugar import.
- the sugar might be imported into the microorganism by a sugar import system independent of phosphoenolpyruvate availability.
- the galactose-proton symporter encoded by the gene gal? that does not involve phosphorylation can be utilized.
- the imported glucose has to be phosphorylated by glucose kinase encoded by the glk gene.
- the expression of at least one gene selected among galP and glk is increased.
- the PTS becomes dispensable and may be eliminated by attenuating the expression of at least one gene selected among pts ⁇ , ptsl or err.
- the efficiency of the PTS is increased by increasing the availability of the metabolite PEP. Due to the attenuation of the gapA activity and of the lower carbon flux toward pyruvate, the amount of PEP in the modified strain of the invention could be limited, leading to a lower amount of glucose transported into the cell.
- a mean is to attenuate the reaction PEP ⁇ pyruvate.
- the expression of at least one gene selected among pykA an ⁇ pykF, coding for the pyruvate kinase enzyme is attenuated in said strain to obtain this result.
- Another way to increase the availability of PEP is to favour the reaction pyruvate ⁇ PEP, catalyzed by phosphoenolpyruvate synthase by increasing the activity of the enzyme.
- This enzyme is encoded by the ppsA gene. Therefore, preferentially in the microorganism the expression of the ppsA gene is increased. Both modifications can be present in the microorganism simultaneously.
- the pyruvate dehydrogenase complex (PDC), converting pyruvate into acetyl-coA has low sensitivity to inhibition by NADH.
- the term "low sensitivity” is defined with reference to the sensitivity of an unmodified enzyme, as already demonstrated in WO 2005/073364.
- such characteristic can be obtained by introducing a specific mutation in the lpd gene (coding for the sub-unit lipoamide dehydrogenase of the PDC) resulting in the replacement of alanine 55 in the protein sequence of the enzyme by a valine.
- the synthesis of the by-product acetate is prevented.
- the reduced co-factor NADH is preferentially oxidised into NAD+ via the respiratory chain with oxygen as a terminal electron acceptor. Therefore, the synthesis of a co-product (e.g. acetate) is not mandatory. It is preferable to avoid such acetate synthesis to optimize the production of 1 ,2-propanediol.
- the activity of at least one enzyme involved in the synthesis of acetate is attenuated.
- the expression of at least one gene selected among ⁇ ckA, pt ⁇ and poxB is attenuated, all these genes coding for enzymes involved in different acetate biosynthesis pathways (see figure 1).
- Another object of the invention is a method for preparing 1 ,2-propanediol wherein an evolved strain such as described previously is grown in an appropriate growth medium containing a carbon source, and then the 1 ,2-propanediol produced is recovered.
- the production of 1,2- propanediol is performed under aerobic, microaerobic or anaerobic conditions.
- the culture conditions (fermentation) for the micro-organisms according to the invention can be readily defined by those skilled in the art.
- bacteria are fermented at temperatures between 20 0 C and 55°C, preferably between 25°C and 40 0 C, and preferably at about 35°C for C. ⁇ cetobutylicum and at about 37°C for E. coli.
- This process can be carried out either in a batch process, in a fed-batch process or in a continuous process.
- the evolved strain may be used to produce 1 ,2-propanediol under aerobic, micro-aerobic or anaerobic conditions.
- 'Under aerobic conditions' means that oxygen is provided to the culture by dissolving the gas into the liquid phase. This could be obtained by (1) sparging oxygen containing gas (e.g. air) into the liquid phase or (2) shaking the vessel containing the culture medium in order to transfer the oxygen contained in the head space into the liquid phase.
- Advantages of the fermentation under aerobic conditions instead of anaerobic conditions is that the presence of oxygen as an electron acceptor improves the capacity of the strain to produce more energy in form of ATP for cellular processes. Therefore the strain has its general metabolism improved.
- Micro-aerobic conditions are defined as culture conditions wherein low percentages of oxygen (e.g. using a mixture of gas containing between 0.1 and 10% of oxygen, completed to 100% with nitrogen), is dissolved into the liquid phase.
- Anaerobic conditions are defined as culture conditions wherein no oxygen is provided to the culture medium. Strictly anaerobic conditions are obtained by sparging an inert gas like nitrogen into the culture medium to remove traces of other gas. Nitrate can be used as an electron acceptor to improve ATP production by the strain and improve its metabolism.
- the culture of strains is conducted in fermentors with a culture medium of known set composition adapted to the bacteria used, containing at least one carbon source.
- a mineral growth medium for E. coli can thus be of identical or similar composition to M9 medium (Anderson, 1946, Proc. Natl. Acad. ScL USA 32:120-128), M63 medium (Miller, 1992; A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York) or a medium such as that defined by Schaefer et al. (1999, Anal. Biochem. 270: 88-96), and in particular the minimum culture medium named MPG described below :
- the pH of the medium is adjusted to 7.4 with sodium hydroxide.
- the method is performed with an evolved strain of E. coli, in a growth medium containing a simple carbon source that can be : arabinose, fructose, galactose, glucose, lactose, maltose sucrose or xylose.
- a simple carbon source that can be : arabinose, fructose, galactose, glucose, lactose, maltose sucrose or xylose.
- An especially preferred simple carbon source is glucose.
- the method is performed with an evolved strain of Clostridium acetobutylicum, in a growth medium containing a simple or a complex carbon source.
- the growth medium for C. acetobutylicum can thus be of identical or similar composition to Clostridial Growth Medium (CGM, Wiesenborn et al., Appl. Environm. Microbiol., 54 : 2717- 2722) or a mineral growth medium as given by Monot et al. (Appl. Environm. Microbiol., 44: 1318-1324) or Vasconcelos et al. (J. Bacterid., 176 : 1443-1450).
- the carbon source used for the culture of C. acetobutylicum is either a simple or a complex carbon.
- the simple carbon source can be arabinose, fructose, galactose, glucose, lactose, maltose sucrose or xylose.
- An especially preferred simple carbon source is glucose.
- the complex carbon source can be starch or hemicellulose.
- An especially preferred complex carbon source is starch.
- the recovered 1 ,2-propanediol is furthermore purified.
- the man skilled in the art knows methods for recovering and purifying the produced 1 ,2-propanediol. These methods are usual processes.
- the PFAM database protein families database of alignments and hidden Markov models http://www.sanger.ac.uk/Software/Pfam/) is a large collection of alignments of protein sequences. Each PFAM makes it possible to visualise multiple alignments, view protein domains, evaluate distributions among organisms, gain access to other databases and visualise known protein structures.
- COGs clusters of orthologous groups of proteins http://www.ncbi.nlm.nih. gov/COG/
- COGs are obtained by comparing protein sequences derived from 66 fully sequenced genomes representing 44 major phylogenetic lines.
- Each COG is defined from at least three lines, making it possible to identify ancient conserved domains.
- Example 1 construction of a modified strain of E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, AldhA, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andh able to evolve toward improved 1,2- propanediol production : a) Construction of a modified strain E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, ldhA::Km, AgIoA, AaIdA, AaIdB, Aedd
- the chloramphenicol resistance cassette was eliminated in the strain E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, idhAr.km, AgIoA, AaIdA, AaIdB, Aedd::cm (See WO2005073364) according to Protocol 1.
- Protocol 1 Elimination of resistance cassettes
- the chloramphenicol and/or kanamycin resistance cassettes were eliminated according to the following technique.
- the plasmid pCP20 carrying the FLP recombinase acting at the FRT sites of the chloramphenicol and/or kanamycin resistance cassettes was introduced into the strain by electroporation. After serial culture at 42°C, the loss of the antibiotic resistance cassettes was checked by PCR analysis with the oligonucleotides given in Table 1.
- the strain obtained was named E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, idhAr.hn, AgIoA, AaIdA, AaIdB, Aedd
- the chloramphenicol resistance cassette was inserted into the ldhA gene deleting most of the gene concerned according to Protocol 2.
- Protocol 2 Introduction of a PCR product for recombination and selection of the recombinants
- the oligonucleotides chosen and given in Table 2 for replacement of a gene or an intergenic region were used to amplify either the chloramphenicol resistance cassette from the plasmid pKD3 or the kanamycin resistance cassette from the plasmid pKD4 (Datsenko, K.A. & Wanner, B. L. (2000)).
- the PCR product obtained was then introduced by electroporation into the recipient strain bearing the plasmid pKD46 in which the system ⁇ Red ( ⁇ , ⁇ ,.exo) expressed greatly favours homologous recombination.
- the antibiotic-resistant transformants were then selected and the insertion of the resistance cassette was checked by PCR analysis with the appropriate oligonucleotides given in Table 1.
- the resulting strain was named E. coli MGl 655 Ipd*, AldhAy.cm, ⁇ tpiA, ApflAB, AadhE, AgIoA, AaIdA, AaIdB, Aedd
- the gene arcA was inactivated in strain E. coli MGl 655 by inserting a kanamycin antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain was named E coli MGl 655 ⁇ rcA::km.
- Control tubes 100 ⁇ l cells
- Tube test 100 ⁇ l of cells + 100 ⁇ l phages Pl of strain MGl 655 with a single gene deleted. - Incubation for 30 min at 30 0 C without shaking.
- the antibiotic-resistant transformants were then selected and the insertion of the deletion was checked by a PCR analysis with the appropriate oligonucleotides given in Table 1.
- the resulting strain was named E. coli MGl 655 Ipd*, ⁇ tpiA, ApflAB, AadhE, AldhA::cm, AgIoA, AaIdA, AaIdB, Aedd , AarcA::km.
- the chloramphenicol and kanamycin resistance cassettes were then eliminated according to Protocol 1.
- the strain obtained was named E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, AldhA, AgIoA, AaIdA, AaIdB, Aedd, AarcA.
- the gene ndh was inactivated by inserting a kanamycin antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain was named E. coli MG1655 Andh::km. f) Construction of a strain E. coli MG 1655 Ipd*, AtpiA, ApIfAB, AadhE, AldhA, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andh
- the resulting strain was named E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, AldhA, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andhvkm.
- the kanamycin resistance cassette was then eliminated according to Protocol 1.
- the strain obtained was named E. coli MGl 655 Ipd*, AtpiA, ApflAB, AadhE, AldhA, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andh.
- Example 2 Evolution of the modified strain E. coli MGl 655 Ipd* AtpiA, ApflAB, AadhE, AldhAr.cm, AgIoA, AaIdA, AaIdB, Aedd in chemostat culture under microaerobic conditions and physiological characterization of evolution :
- the strain E. coli MGl 655 Ipd* AtpiA, ApflAB, AadhE, AldhAr.cm, AgIoA, AaIdA, AaIdB, Aedd was cultivated in continuous culture under anaerobic conditions on one side and under microaerobic conditions (1% oxygen) on the other side in the culture medium MPG such as described previously, with excess glucose (from 20 g/1 initially with addition if the glucose becomes exhausted).
- the temperature was set at 37°C and the pH was regulated at 6.5 by addition of base.
- the evolution of the strain in the chemostats was followed by the increase of the biomass concentration coupled with the increase of the concentrations of the product, 1 ,2-propanediol and the co-product acetate, over several weeks (from 4 weeks up to 6 months). This denoted the improvement of the performances of the strains.
- the evolution was done.
- the characteristics of the strains before and after evolution were assessed. Single colonies representing individual clones were isolated on Petri dishes. These clones were assessed using the initial strain as control in an Erlenmeyer flask assay, using the same medium MPG used in the chemostat culture.
- Example 3 reconstruction of tpiA gene in the selected evolved strain of E. coli MG1655 Ipd*, AtpiA, ⁇ pflAB, AadhE, AldhA::cm, AgIoA, AaIdA, AaIdB, Aedd : a) Construction of a modified strain E. coli MGl 655 tpiAr.km
- a kanamycin antibiotic resistance cassette was inserted upstream of the gene tpiA according to the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain was named E coli MGl 655 tpiAy.km. Then the reconstruction of the gene tpiA into the evolved strain E. coli MGl 655 Ipd*,
- AtpiA ApIfAB, AadhE, AldhAr.cm, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andh was performed using the transduction technique with phage Pl described in Protocol 3.
- the resulting strain was named evolved E. coli MG 1655 Ipd*, tpiArc: :km, ApIfAB, AadhE, AldhAr.cm, AgIoA, AaIdA, AaIdB, Aedd, AarcA, Andh.
- the kanamycin and chloramphenicol resistance cassettes were then eliminated according to
- Example 4 Modifications of the 'evolved E. coli tpiArc' : attenuation of the gapA gene; deletion of the genes pykA and /jj ⁇ F; over-expression of ppsA gene with a vector pJB137- PgapA-ppsA a) Replacement of the natural gap A promoter with the synthetic short Ftrcl ⁇ promoter :
- the gene pykA is inactivated by inserting a kanamycin antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain is named 'evolved E. coli tpiArc ' Ptrc ⁇ 6-gapA ApykA::km.
- the kanamycin resistance cassette is then eliminated according to Protocol 1.
- the strain obtained is named 'evolved E. coli tpiArc' Ptrc ⁇ 6-gapA ApykA.
- the gene pykF is inactivated by inserting a kanamycin antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain is named 'evolved E. coli tpiArc' Ptrcl ⁇ - gapA, ApykA ApykF::km.
- the strain obtained is named 'evolved E. coli tpiArc' Ptrc ⁇ 6-gap A, ApykA, ApykF. d) Introduction of an expression vector p JBl 37-PgapA-pps 1 A into the strain
- the ppsA gene was expressed from the plasmid pJB137 using the gapA promoter.
- the gene ppsA was PCR amplified from genomic DNA of E. coli MGl 655 using the following oligonucleotides:
- gapA-ppsAF consisting of 65 bases (SEQ ID NO 53) ccttttattcactaacaaatagctggtggaatatATGTCCAACAATGGCTCGTCACCGCTGGTGC with:
- ppsAR consisting of 43 bases (SEQ ID NO 54) aatcgcaagcttGAATCCGGTTATTTCTTCAGTTCAGCCAGGC with: a region (upper letters) homologous to the sequence (1782758 -1782780) the region of the geneppsA (1785136 to 1782758) - a restriction site Hindl ⁇ l (underlined letters)
- gap A promoter region of the E. coli gene gapA was amplified using the following oligonucleotides:
- gapA-ppsAR consisting of 65 bases (SEQ ID NO 55) GCACCAGCGGTGACGAGCCATTGTTGGACATatattccaccagctatttgttagtgaataaaagg with:
- gapAF consisting of 33 bases (SEQ ID NO 56) ACGTCCCGGGcaagcccaaaggaagagtgaggc with: a region (lower letters) homologous to the gap A promoteur (1860639 - 1860661). a restriction site Smal (underlined letters)
- the plasmid pJB137-PgapA-ppsA is introduced into the strain 'evolved E. coli tpiArc ' Ptrcl ⁇ -gapA, ApykA, ApykF.
- the strain obtained is named 'evolved E. coli tpiArc', Ptrcl ⁇ -gapA, ApykA, ApykF, (pJB137-PgapA-ppsA).
- Example 5 construction of a strain 'evolved E. coli tpiArc' Ptrcl ⁇ -gapA, ApykA, ApykF, AackA-pta, ApoxB (pJB137-PgapA-ppsA) able to produce 1,2-propanediol without acetate as by-product a) Construction of a modified strain E. coli MG1655 ⁇ ackA-pta::cm
- the genes ackA and pta are inactivated by inserting a chloramphenicol antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain is named E coli MG1655 AackA-pta::cm.
- the gene poxB is inactivated by inserting a chloramphenicol antibiotic resistance cassette and deleting most of the gene concerned using the technique described in Protocol 2 with the oligonucleotides given in Table 2.
- the resulting strain is named evolved E. coli tpiArc Ptrcl ⁇ -gapA, ApykA, ApykF, AackA- pta, ApoxB:: cm.
- the chloramphenicol resistance cassette is then eliminated according to protocol 1.
- the strain obtained is named evolved E. coli tpiArc Ptrcl ⁇ -gapA, ApykA, ApykF, AackA-pta, ApoxB.
- the plasmid pJB137-PgapA-ppsA is introduced into the strain evolved E. coli tpiArc Ptrcl-gapA, ApykA, ApykF, AackA-pta, ApoxB.
- the strain obtained is named evolved E. coli tpiArc Ptrcl ⁇ -gapA, ApykA, ApykF, AackA-pta, ApoxB (pJB137-PgapA-ppsA).
- Example 6 Comparison of the different evolved strains for 1,2-propanediol production under aerobic conditions
- strains obtained as described in Example 4 and the control strains (control 1 : MGl 655 lpd* AtpiA ApflAB AadhE AldhA::Cm AgIoA AaId, AaIdB Aedd evolved under anaerobic conditions and control 2 : MGl 655 lpd* AtpiA ApflAB AadhE AldhA: :Cm AgIoA AaId, AaIdB Aedd evolved under microaerobic conditions) were cultivated in an Erlenmeyer flask assay under aerobic conditions in minimal medium supplemented with yeast extract and with glucose as carbon source.
- the culture was carried out at 34°C and the pH was maintained by buffering the culture medium with MOPS.
- 1,2-propanediol, acetol and residual glucose in the fermentation broth were analysed by HPLC and the yields of 1 ,2-propanediol over glucose and 1 ,2- propanediol + acetol over glucose were calculated.
- the best strain is then selected for a fermenter fed-batch culture.
- Example 7 Production of 1,2-propanediol in fed-batch culture with the best strain
- the best strain selected in the previous experiment is cultivated in a 21 fermenter using a fed-batch protocol.
- the temperature of the culture is maintained constant at 37 0 C and the pH is permanently adjusted to values between 6.5 and 8 using an NH 4 OH solution.
- the agitation rate is maintained between 200 and 300 rpm during the batch phase and is increased to up to 1000 rpm at the end of the fed-batch phase.
- the concentration of dissolved oxygen is maintained at values between 30 and
- the fed-batch is started with an initial flow rate between 0.3 and 0.5 ml/h, and a progressive increase up to flow rate values between 2.5 and 3.5 ml/h. At this point the flow rate is maintained constant for 24 to 48 hours.
- the medium of the fed is based on minimal media containing glucose at concentrations between 300 and 500 g/1.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK08714246.9T DK2109681T3 (en) | 2007-03-23 | 2008-03-21 | NEW MICROORGANISMS FOR THE PREPARATION OF 1,2-PROPANDIOL OBTAINED BY A COMBINATION OF EVOLUTION AND RATIONAL DESIGN |
BRPI0808972A BRPI0808972B1 (en) | 2007-03-23 | 2008-03-21 | Method for the preparation of an Escherichia coli strain for the production of 1,2-propanediol from a carbon source |
EP08714246.9A EP2109681B1 (en) | 2007-03-23 | 2008-03-21 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design. |
KR1020097022123A KR101528943B1 (en) | 2007-03-23 | 2008-03-21 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
CA2679989A CA2679989C (en) | 2007-03-23 | 2008-03-21 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
ES08714246.9T ES2525796T3 (en) | 2007-03-23 | 2008-03-21 | New microorganisms for the production of 1,2-propanediol obtained through a combination of evolution and rational design |
JP2009554045A JP5570821B2 (en) | 2007-03-23 | 2008-03-21 | Novel microorganisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
US12/532,405 US8298807B2 (en) | 2007-03-23 | 2008-03-21 | Micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
MX2009010229A MX2009010229A (en) | 2007-03-23 | 2008-03-21 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design. |
IL200705A IL200705A0 (en) | 2007-03-23 | 2009-09-03 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IB2007001680 | 2007-03-23 | ||
IBPCT/IB2007/001680 | 2007-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008116852A1 true WO2008116852A1 (en) | 2008-10-02 |
Family
ID=38814484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2008/053445 WO2008116852A1 (en) | 2007-03-23 | 2008-03-21 | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design. |
Country Status (14)
Country | Link |
---|---|
US (1) | US8298807B2 (en) |
EP (1) | EP2109681B1 (en) |
JP (1) | JP5570821B2 (en) |
KR (1) | KR101528943B1 (en) |
CN (1) | CN101641446A (en) |
AR (1) | AR066196A1 (en) |
BR (1) | BRPI0808972B1 (en) |
CA (1) | CA2679989C (en) |
DK (1) | DK2109681T3 (en) |
ES (1) | ES2525796T3 (en) |
IL (1) | IL200705A0 (en) |
MX (1) | MX2009010229A (en) |
TW (1) | TW200904984A (en) |
WO (1) | WO2008116852A1 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2233562A1 (en) | 2009-03-24 | 2010-09-29 | Metabolic Explorer | Method for producing high amount of glycolic acid by fermentation |
WO2011012697A2 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant yqhd enzyme for the production of a biochemical by fermentation |
WO2011012693A1 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant methylglyoxal synthase (mgs) for the production of a biochemical by fermentation |
WO2011012702A1 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant glycerol dehydrogenase (glydh) for the production of a biochemical by fermentation |
JP2012529267A (en) * | 2009-06-04 | 2012-11-22 | ゲノマチカ, インク. | Microorganisms and related methods for the production of 1,4-butanediol |
EP2532751A1 (en) * | 2011-06-10 | 2012-12-12 | Metabolic Explorer | Use of inducible promoters in the fermentative production of 1,2-propanediol |
WO2012172050A1 (en) | 2011-06-15 | 2012-12-20 | B.R.A.I.N. Biotechnology Research And Information Network Ag | New means and methods for producing propanediol |
EP3050970A1 (en) | 2015-01-28 | 2016-08-03 | Metabolic Explorer | Modified microorganism for optimized production of 1,4-butanediol |
WO2016162712A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxyburyrate |
WO2016162442A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | A modified microorganism for the optimized production of 2,4-dihydroxyburyrate with enhanced 2,4-dihydroxybutyrate efflux |
WO2017025766A1 (en) | 2015-08-07 | 2017-02-16 | Metabolic Explorer | Protein thiocarboxylate-dependent l-methionine production by fermentation |
WO2017042602A1 (en) | 2015-09-10 | 2017-03-16 | Metabolic Explorer | New lactaldehyde reductases for the production of 1,2-propanediol |
US9617567B2 (en) | 2008-11-07 | 2017-04-11 | Metabolic Explorer | Use of sucrose as substrate for fermentative production of 1,2-propanediol |
WO2017068385A1 (en) | 2015-10-23 | 2017-04-27 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
WO2018007560A1 (en) | 2016-07-08 | 2018-01-11 | Metabolic Explorer | Method for the fermentative production of molecules of interest by microorganisms comprising genes coding sugar phosphotransferase system (pts) |
EP3342873A1 (en) | 2016-12-29 | 2018-07-04 | Metabolic Explorer | Conversion of methylglyoxal into hydroxyacetone using enzymes and applications thereof |
EP3470512A1 (en) | 2017-10-10 | 2019-04-17 | Metabolic Explorer | Mutant phosphoserine aminotransferase for the conversion of homoserine into 4-hydroxy-2-ketobutyrate |
US11034985B2 (en) | 2015-11-27 | 2021-06-15 | Evonik Operations Gmbh | Method for producing L-methionine |
US12098403B2 (en) | 2010-07-12 | 2024-09-24 | Inbiose N.V. | Metabolically engineered organisms for the production of added value bio-products |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8647642B2 (en) | 2008-09-18 | 2014-02-11 | Aviex Technologies, Llc | Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
KR102245274B1 (en) | 2019-01-28 | 2021-04-27 | 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 | A novel genome-reduced microorganism and a method of producing thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037204A1 (en) | 1997-02-19 | 1998-08-27 | Wisconsin Alumni Research Foundation | Microbial production of 1,2-propanediol from sugar |
WO2004033646A2 (en) | 2002-10-04 | 2004-04-22 | E.I. Du Pont De Nemours And Company | Process for the biological production of 1,3-propanediol with high yield |
WO2005073364A2 (en) | 2004-01-12 | 2005-08-11 | Metabolic Explorer | Advanced microorganism for producing 1,2-propanediol |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1597364B1 (en) | 2003-02-18 | 2013-07-24 | Metabolic Explorer | Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways |
-
2008
- 2008-03-21 TW TW097110003A patent/TW200904984A/en unknown
- 2008-03-21 KR KR1020097022123A patent/KR101528943B1/en active IP Right Grant
- 2008-03-21 WO PCT/EP2008/053445 patent/WO2008116852A1/en active Application Filing
- 2008-03-21 JP JP2009554045A patent/JP5570821B2/en not_active Expired - Fee Related
- 2008-03-21 DK DK08714246.9T patent/DK2109681T3/en active
- 2008-03-21 CA CA2679989A patent/CA2679989C/en active Active
- 2008-03-21 CN CN200880009616A patent/CN101641446A/en active Pending
- 2008-03-21 EP EP08714246.9A patent/EP2109681B1/en not_active Not-in-force
- 2008-03-21 US US12/532,405 patent/US8298807B2/en active Active
- 2008-03-21 ES ES08714246.9T patent/ES2525796T3/en active Active
- 2008-03-21 MX MX2009010229A patent/MX2009010229A/en active IP Right Grant
- 2008-03-21 BR BRPI0808972A patent/BRPI0808972B1/en not_active IP Right Cessation
- 2008-03-25 AR ARP080101213A patent/AR066196A1/en active IP Right Grant
-
2009
- 2009-09-03 IL IL200705A patent/IL200705A0/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037204A1 (en) | 1997-02-19 | 1998-08-27 | Wisconsin Alumni Research Foundation | Microbial production of 1,2-propanediol from sugar |
US6087140A (en) | 1997-02-19 | 2000-07-11 | Wisconsin Alumni Research Foundation | Microbial production of 1,2-propanediol from sugar |
US6303352B1 (en) | 1997-02-19 | 2001-10-16 | Wisconsin Alumni Research Foundation | Microbial production of 1,2-propanediol from sugar |
WO2004033646A2 (en) | 2002-10-04 | 2004-04-22 | E.I. Du Pont De Nemours And Company | Process for the biological production of 1,3-propanediol with high yield |
WO2005073364A2 (en) | 2004-01-12 | 2005-08-11 | Metabolic Explorer | Advanced microorganism for producing 1,2-propanediol |
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9617567B2 (en) | 2008-11-07 | 2017-04-11 | Metabolic Explorer | Use of sucrose as substrate for fermentative production of 1,2-propanediol |
WO2010108909A1 (en) | 2009-03-24 | 2010-09-30 | Metabolic Explorer | Method for producting high amount of glycolic acid by fermentation |
EP2233562A1 (en) | 2009-03-24 | 2010-09-29 | Metabolic Explorer | Method for producing high amount of glycolic acid by fermentation |
US8945888B2 (en) | 2009-03-24 | 2015-02-03 | Metabolic Explorer | Method for producing high amount of glycolic acid by fermentation |
US9434964B2 (en) | 2009-06-04 | 2016-09-06 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
JP2022031648A (en) * | 2009-06-04 | 2022-02-22 | ゲノマチカ, インク. | Microbial organisms for producing 1,4-butanediol and related methods |
US11401534B2 (en) | 2009-06-04 | 2022-08-02 | Genomatica, Inc. | Microorganisms for the production of 1,4- butanediol and related methods |
US10273508B2 (en) | 2009-06-04 | 2019-04-30 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
JP2012529267A (en) * | 2009-06-04 | 2012-11-22 | ゲノマチカ, インク. | Microorganisms and related methods for the production of 1,4-butanediol |
WO2011012702A1 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant glycerol dehydrogenase (glydh) for the production of a biochemical by fermentation |
WO2011012693A1 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant methylglyoxal synthase (mgs) for the production of a biochemical by fermentation |
WO2011012697A2 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant yqhd enzyme for the production of a biochemical by fermentation |
US12098403B2 (en) | 2010-07-12 | 2024-09-24 | Inbiose N.V. | Metabolically engineered organisms for the production of added value bio-products |
EP2532751A1 (en) * | 2011-06-10 | 2012-12-12 | Metabolic Explorer | Use of inducible promoters in the fermentative production of 1,2-propanediol |
WO2012172050A1 (en) | 2011-06-15 | 2012-12-20 | B.R.A.I.N. Biotechnology Research And Information Network Ag | New means and methods for producing propanediol |
EP3050970A1 (en) | 2015-01-28 | 2016-08-03 | Metabolic Explorer | Modified microorganism for optimized production of 1,4-butanediol |
WO2016162712A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | Modified microorganism for the optimized production of 2,4-dihydroxyburyrate |
WO2016162442A1 (en) | 2015-04-07 | 2016-10-13 | Metabolic Explorer | A modified microorganism for the optimized production of 2,4-dihydroxyburyrate with enhanced 2,4-dihydroxybutyrate efflux |
WO2017025766A1 (en) | 2015-08-07 | 2017-02-16 | Metabolic Explorer | Protein thiocarboxylate-dependent l-methionine production by fermentation |
WO2017042602A1 (en) | 2015-09-10 | 2017-03-16 | Metabolic Explorer | New lactaldehyde reductases for the production of 1,2-propanediol |
US10801050B2 (en) | 2015-10-23 | 2020-10-13 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
WO2017068385A1 (en) | 2015-10-23 | 2017-04-27 | Metabolic Explorer | Microorganism modified for the assimilation of levulinic acid |
US11034985B2 (en) | 2015-11-27 | 2021-06-15 | Evonik Operations Gmbh | Method for producing L-methionine |
WO2018007560A1 (en) | 2016-07-08 | 2018-01-11 | Metabolic Explorer | Method for the fermentative production of molecules of interest by microorganisms comprising genes coding sugar phosphotransferase system (pts) |
WO2018122388A1 (en) | 2016-12-29 | 2018-07-05 | Metabolic Explorer | Conversion of methylglyoxal into hydroxyacetone using novel enzymes and applications thereof |
US10889840B2 (en) | 2016-12-29 | 2021-01-12 | Metabolic Explorer | Conversion of methylglyoxal into hydroxyacetone using novel enzymes and applications thereof |
EP3342873A1 (en) | 2016-12-29 | 2018-07-04 | Metabolic Explorer | Conversion of methylglyoxal into hydroxyacetone using enzymes and applications thereof |
EP3470512A1 (en) | 2017-10-10 | 2019-04-17 | Metabolic Explorer | Mutant phosphoserine aminotransferase for the conversion of homoserine into 4-hydroxy-2-ketobutyrate |
WO2019072883A1 (en) | 2017-10-10 | 2019-04-18 | Metabolic Explorer | Mutant phosphoserine aminotransferase for the conversion of homoserine into 4-hydroxy-2-ketobutyrate |
Also Published As
Publication number | Publication date |
---|---|
KR101528943B1 (en) | 2015-06-15 |
EP2109681B1 (en) | 2014-10-15 |
EP2109681A1 (en) | 2009-10-21 |
MX2009010229A (en) | 2009-10-26 |
BRPI0808972A2 (en) | 2014-08-26 |
CN101641446A (en) | 2010-02-03 |
JP5570821B2 (en) | 2014-08-13 |
AR066196A1 (en) | 2009-08-05 |
CA2679989A1 (en) | 2008-10-02 |
KR20100015810A (en) | 2010-02-12 |
DK2109681T3 (en) | 2014-12-08 |
BRPI0808972B1 (en) | 2016-11-29 |
ES2525796T3 (en) | 2014-12-30 |
US20100285547A1 (en) | 2010-11-11 |
IL200705A0 (en) | 2010-05-17 |
US8298807B2 (en) | 2012-10-30 |
CA2679989C (en) | 2015-07-07 |
TW200904984A (en) | 2009-02-01 |
JP2010521958A (en) | 2010-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2679989C (en) | New micro-organisms for the production of 1,2-propanediol obtained by a combination of evolution and rational design | |
US20100261239A1 (en) | Metabolically engineered microorganism useful for the production of 1,2-propanediol | |
KR101734793B1 (en) | Microorganisms and methods for production of 1,2-propanediol and acetol | |
US8252579B2 (en) | Evolved micro-organisms for the production of 1,2-propanediol | |
EP2459711B1 (en) | Mutant YqhD enzyme for the production of a biochemical by fermentation | |
WO2009115114A1 (en) | Polypeptide having glyoxylase iii activity, polynucleotide encoding the same and uses thereof | |
US20110262980A1 (en) | Micro-organisms for the production of acetol obtained by a combination of evolution and rational design | |
US20100279369A1 (en) | Metabolically engineered microorganism useful for the production of acetol | |
EP2459720B1 (en) | Mutant glycerol dehydrogenase (glydh) for the production of a biochemical by fermentation | |
MXPA06007929A (en) | Advanced microorganism for producing 1,2-propanediol | |
EP2265716A1 (en) | Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880009616.8 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008714246 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08714246 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2679989 Country of ref document: CA Ref document number: 200705 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5338/CHENP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009554045 Country of ref document: JP Ref document number: PI20093887 Country of ref document: MY |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12532405 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/010229 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20097022123 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0808972 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090917 |